An observational study in Chronic Spontaneous Urticaria, sponsored by Sohag University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-08-15.
Sponsored by Sohag University · Observational
adenosine deaminase activity (ADA) has been reported to be elevated in various diseases such as psoriasis, acne and juvenile idiopathic arthritis. There is no previous studies that assessed ADA in chronic spontaneous urticaria (CSU) .
237 studies on the registry are indexed under Urticaria; 26 are open to participants now.
This study's planned enrollment of 90 is below the median of 162 across 52 observational studies indexed under Urticaria.
Browse Urticaria studies →Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Settings: Dermatology outpatient clinics and Central Research Lab at Sohag University.
Study population: The study will include adult patients complaining of CSU and a group of age and sex-matched healthy controls (blood donors).
Exclusion Criteria:
Adult patients complaining of chronic spontaneous urticaria (CSU)
Diagnostic Test: Adenosine deaminase serum level · Diagnostic Test: IgE antibodies serum level
A group of age and sex-matched healthy controls (blood donors).
Diagnostic Test: Adenosine deaminase serum level · Diagnostic Test: IgE antibodies serum level
Adenosine deaminase will be measured by enzymatic (clorometric / kinetic) method (Diazyme laboratories, San Diego, California, USA).
Level of IgE will be measured by electrochemiluminesence immunoassay (ECLIA, automatic cobase immunoassay, Roche Diagnostics GmbH, Mannheim, USA).
Serum level of adenosine deaminase
Difference in serum level of adenosine deaminase between CSU group and control group
Time frame: 3 months
Serum level of IgE
Difference in serum level of IgE between CSU group and control group
Time frame: 3 months
No study locations are listed for this record.
Plan to share: Yes — IPD will be shared upon request to the study director
Supporting information: Study protocol, Sap, Csr
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sohag University